Marton K.
- Country
- Norway
- Department
- Department of Neurology
Research Overview
Data & Insights
Has run more than one trial at 0 of 5 partner sites.
Specializations
Neurodegenerative Disorders
Investigator Marton König focuses on diseases characterized by progressive neuronal loss, including Alzheimer's Disease and Amyotrophic Lateral Sclerosis, as well as early cognitive decline such as Mild cognitive impairment.
- Alzheimer's Disease
- Amyotrophic Lateral Sclerosis
- Mild cognitive impairment
Research aims to elucidate pathogenic mechanisms and identify disease‑modifying interventions.
Cerebrovascular and Stroke Medicine
Clinical work emphasizes acute and chronic vascular brain injury, notably Acute ischemic stroke, and associated cardiac rhythm disorders such as Atrial fibrillation after stress and broader atherosclerotic risk.
- Acute ischemic stroke
- Atrial fibrillation after stress
- Atherosclerotic cardiovascular disease
Efforts target prevention, acute management, and long‑term vascular health.
Neuro‑immunology and Autoimmune Neurology
Investigator König engages in immune‑mediated neurological conditions, including Multiple Sclerosis, Chronic Inflammatory Demyelinating Polyneuropathy, and antibody‑driven disorders such as Generalized Myasthenia Gravis.
- Multiple Sclerosis
- Chronic Inflammatory Demyelinating Polyneuropathy
- Generalized Myasthenia Gravis
Studies explore immunopathology and therapeutic modulation of autoimmunity.
Neuro‑oncology
Research portfolio includes malignant brain tumors such as Glioblastoma, metastatic disease exemplified by Brain metastases from non‑small‑cell lung cancer, and pediatric solid tumours like Medulloblastoma.
- Glioblastoma
- Brain metastases from non‑small‑cell lung cancer
- Medulloblastoma
Focus lies on molecular characterization and innovative treatment strategies.
Neuromuscular and Rare Genetic Neurology
Investigator König addresses hereditary neuromuscular disorders, including Duchenne Muscular Dystrophy, DNA‑repair syndromes such as Ataxia Telangiectasia, and motor neuron disease exemplified by Spinal Muscular Atrophy.
- Duchenne Muscular Dystrophy
- Ataxia Telangiectasia
- Spinal Muscular Atrophy
Efforts aim to define disease pathways and assess emerging therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.